Longevity & AgingArticle de rechercheAccès libre

New Danish Study Tracks Who Recovers From Whiplash and Why

A prospective cohort study will follow 100 whiplash patients for 12 months, using HRV, hair cortisol, and clinical tools to predict chronic pain.

vendredi 25 septembre 2026 1 vue
Publié dans BMJ Open
Close-up of a clinician attaching a heart rate monitor to a patient's wrist in a calm emergency department room

Résumé

Researchers in Denmark are launching a 12-month prospective cohort study enrolling 100 adults with post-traumatic neck pain from three emergency departments. The study will measure heart rate variability (HRV), hair cortisol, pain sensitivity, and self-reported symptoms at baseline and at 3, 6, and 12 months. Two existing clinical prediction tools—WhipPredict and DWGRAS—will be validated and compared in a European acute-care context. The goal is to identify who is at risk of developing chronic moderate-to-severe disability (affecting 15–25% of whiplash patients), improve early screening, and quantify health economic costs. Findings could enable clinicians to deliver targeted early interventions and reduce long-term suffering and societal burden.

Résumé détaillé

Post-traumatic neck pain, commonly known as whiplash-associated disorder, affects hundreds of thousands annually worldwide and carries enormous human and economic costs. While most patients recover, 15–25% experience moderate-to-severe symptoms and functional impairment one year after injury, placing them at risk of leaving the labour market. A 2008 estimate placed European insurance claims alone at $500 million. Despite this burden, early prediction and targeted intervention remain underdeveloped, motivating this new Danish prospective cohort study.

The study will recruit 100 adults (≥18 years) presenting to one of three emergency departments in Denmark within 72 hours of an accident causing neck pain. Baseline assessment combines self-reported measures (pain intensity via Neck Disability Index, disability, sleep quality, post-traumatic stress) with objective biomarkers including heart rate variability (HRV), resting heart rate, respiration monitoring, and hair cortisol for retrospective pre-trauma stress estimation. Quantitative sensory testing and cervical range of motion will also be performed. Follow-up occurs at 3, 6, and 12 months post-trauma, supplemented by register data on labour market participation and healthcare utilisation.

A central focus is validating two existing clinical prediction tools—Australia's WhipPredict (using age, NDI score, and hyperarousal symptoms) and Denmark's DWGRAS (based on neurological symptoms, pain severity, and cervical range of motion)—in a European acute-care context where neither has been extensively tested. The study will also explore whether adding HRV measurements improves predictive accuracy. Prior neurobiological research supports HRV as a marker of autonomic dysregulation; low HRV has been associated with post-traumatic stress disorder (PTSD) development, and one prior study found that HRV measured 2 days post-accident identified 72% of those who later developed PTSD.

Hair cortisol, reflecting cumulative cortisol secretion over weeks to months, will serve as a measure of pre-trauma stress—testing the hypothesis that pre-existing stress vulnerabilities moderate long-term recovery outcomes. Health economic analyses will compare costs between recovered and non-recovered groups (NDI <10% vs >32%) at 12 months. Statistical approaches include ROC curve analysis, logistic regression with and without biomarkers, and moderation analysis.

The sample size of 100 is justified for regression analyses; a minimum of 80 participants (accounting for 25% dropout) is needed to detect an AUC of 0.80 with 90% power based on an estimated 15% chronicity rate. The study is registered (NCT06176209) and ethically approved. If prediction tools prove effective, clinician workshops will be organised. Results will be published regardless of outcome, advancing the evidence base for early, personalised care in whiplash.

Principales conclusions

  • 15–25% of whiplash patients develop moderate-to-severe disability lasting 12 months, driving high societal costs.
  • HRV measured within 72 hours may identify autonomic dysregulation predictive of PTSD and chronic pain.
  • Hair cortisol will be used as a novel biomarker of pre-trauma stress vulnerability in neck pain recovery.
  • Two clinical prediction tools (WhipPredict and DWGRAS) will be validated head-to-head in an acute European setting.
  • Health economic costs will be compared between recovered and non-recovered groups at 12 months post-injury.

Méthodologie

Prospective cohort study recruiting 100 adults within 72 hours of a neck-pain-causing accident across three Danish emergency departments, with follow-up at 3, 6, and 12 months. Baseline assessment includes self-report questionnaires, HRV, hair cortisol, quantitative sensory testing, and cervical range of motion. Analyses will use ROC curves, logistic regression, and moderation analysis.

Limites de l'étude

Recruitment is limited to three Danish emergency departments, potentially excluding patients who do not seek ED care and limiting generalisability internationally. The 100-participant sample, while sufficient for primary analyses, may limit subgroup analyses. This is a protocol paper; no outcome data are yet available.

Ce résumé vous a plu ?

Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.

Saisissez votre e-mail pour vous abonner :